Related Experiment Videos
Amipaque as contrast medium for intraosseous phlebography.
Acta Radiologica: Diagnosis
|January 1, 1978
Summary
Amipaque 260 caused less pain than Isopaque 260 during intraosseous phlebography for ankle varicose ulcerations. This study found no complications or side effects in patients over a one-year observation period.
Area of Science:
- Radiology
- Vascular Surgery
- Pain Management
Background:
- Varicose ulcerations in the ankle region are a common clinical challenge.
- Intraosseous phlebography is a diagnostic procedure used in evaluating venous insufficiency.
- Contrast agents are essential for phlebography but can cause patient discomfort.
Purpose of the Study:
- To compare the pain experienced by patients undergoing intraosseous phlebography using Amipaque 260 versus Isopaque 260.
- To assess the safety and side effect profiles of Amipaque 260 and Isopaque 260 in this context.
Main Methods:
- A comparative study involving patients with ankle varicose ulcerations.
- Intraosseous phlebography was performed using either Amipaque 260 or Isopaque 260.
- Pain levels and adverse events were systematically recorded and monitored.
Main Results:
- Amipaque 260 was associated with significantly less pain compared to Isopaque 260.
- No complications or adverse side effects were reported for either contrast agent during the one-year follow-up.
- Patient-reported pain is a critical factor in the tolerability of contrast media.
Conclusions:
- Amipaque 260 offers a more comfortable alternative to Isopaque 260 for intraosseous phlebography in patients with ankle varicose ulcerations.
- Both contrast agents demonstrated a favorable safety profile with no observed complications.
- Minimizing patient discomfort is crucial in diagnostic procedures like phlebography.